Patents by Inventor Michio Kanekiyo

Michio Kanekiyo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUS
    Publication number: 20210349097
    Abstract: Biomarkers are provided that predict whether a human subject having a renal cell carcinoma is responsive to a combination therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof (e.g., lenvatinib mesylate) and everolimus. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing a renal cell carcinoma.
    Type: Application
    Filed: October 2, 2019
    Publication date: November 11, 2021
    Inventors: Yasuhiro Funahashi, Yukinori Minoshima, Michio Kanekiyo, Masahiro Matsuki, Yusuke Adachi, Kotaro Kodama
  • BIOMARKERS FOR A THERAPY COMPRISING A SORAFENIB COMPOUND
    Publication number: 20210333281
    Abstract: Biomarkers are provided that predict whether a subject having a hepatocellular carcinoma is responsive to a therapy comprising soratenib or a pharmaceutically acceptable salt thereof. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing a hepatocellular carcinoma.
    Type: Application
    Filed: October 2, 2019
    Publication date: October 28, 2021
    Inventors: Yasuhiro Funahashi, Yukinori Minoshima, Michio Kanekiyo, Saori Miyano, Taisuke Hoshi